Molecular Quality Control Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2028

 

Molecular quality control is primarily used to monitor the efficacy of in vitro nucleic acid testing procedures for viral load assays, healthcare-associated infections (HAIs) such as bloodstream infections, urinary tract infections, pneumonia, and other infections associated with sexually transmitted diseases. The primary goal of molecular quality control is to test molecular diagnostic products, detect flaws, and report them to management.

The Molecular Quality Control Market is divided into several applications, including infectious disease diagnostics, oncology testing, genetic testing, and others.

The rising adoption of third-party quality controls, the increasing number of accredited clinical laboratories, the rising demand for external quality assessment support, rising government funding to support genomics projects, rising demand for personalised medicines, declining costs of sequencing procedures, and rising prevalence of infectious diseases, cancer, and genetic diseases are driving the growth of this market.

As the prevalence of cancers, HIV, and other diseases rises, the market for Molecular Quality Control Market is expected to grow significantly between 2022 and 2028. Molecular quality control refers to the testing and reporting of any irregularities in diagnostic products that may affect decisions about product approval for use in laboratories. Molecular laboratories employ stringent quality control (QC) procedures to monitor testing for both systematic and random errors, as well as to detect immediate shifts in data and abnormalities in long-term trends. Early detection of potential anomalies is critical for laboratories because it allows them to respond quickly and avoid negative impacts on patient data.

Various factors, such as the steady increase in the number of accredited clinical laboratories, are driving global molecular quality control market trends. For example, in September 2021, the CAP (College of American Pathologists) granted accreditation to UC Berkeley's Innovative Genomics Institute Clinical Laboratory based on the results of an on-site inspection conducted as part of the CAP's Accreditation Programs. Molecular Quality Control Market increase in clinical facilities will create an urgent need for thorough monitoring and testing for potential irregularities in diagnostic products, which may increase demand for molecular quality control solutions in the coming years.

Key Players

Seracare Life Sciences, Inc., Zeptometrix, Thermo Fisher Scientific, Abbott Laboratories, Maine Molecular Quality Controls, Inc., Quidel, Qnostics, Bio-Rad Laboratories, Roche Diagnostics, Microbiologics, Inc., and Theranostica are key players in the global molecular quality control market.